Enliven Therapeutics, Inc. · NASDAQ:ELVN
FMR LLC reported a 13.30% stake in Enliven Therapeutics, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 5, 2025
FMR LLC reported a 13.30% stake in Enliven Therapeutics, Inc., 7,870,219 shares, as a passive investor on Sep 30, 2025. Filed Nov 5, 2025 (Schedule 13G/A).
- Stake
- 13.30%
- Shares
- 7,870,219
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| FMR LLC | 13.30% | 7,870,219 |
| Abigail P. Johnson | 13.30% | 7,870,219 |
Source
Related
- Enliven Therapeutics, Inc.
- FMR LLC
- Enliven Therapeutics, Inc. shareholders
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Form 4 · Hohl Benjamin · Oct 21, 2026
- Form 4 · Collins Helen Louise · Oct 21, 2026
- Form 4 · Garland J. Scott · Oct 5, 2026
- Form 4 · Hohl Benjamin · Sep 21, 2026
- Form 4 · Collins Helen Louise · Sep 21, 2026